David B. Neau

In situ targeted base editing of bacteria in the mouse gut

A Gram-negative-selective antibiotic that spares the gut microbiome

Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase

C-terminal modification of the insulin B:11–23 peptide creates superagonists in mouse and human type 1 diabetes